MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
Projects
PGBD5 promotes site-specific oncogenic mutations in human tumors
Integrating genomics into clinical pediatric oncology using the molecular tumor board at MSKCC.
Genomic DNA transposition induced by human PGBD5.
Read More
Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance
